Introduction
The subject has been chosen for three reasons. First, because in the space of just a few years the rhesus blood factor has assumed world-wide interest and import, and has already come to merit a most important place in the realm of obstetrics. Secondly, its practical significance does not yet seem to be fully appreciated or realized, and thirdly, study has proved this subject to be much more complicated than was at first thought.
A considerable amount of knowledge has been accumulated in these last few years, but there is still much more to be found out, both practically, and on the research side as well. The picture is incomplete and its completion depends on the close interdigitation of the practical with the research side, and the seeing that no available material is missed.
The purpose of this article is not to diverge into research problems or those relating to blood transfusion, but to indicate the particular influence that this recent research has on practical obstetrics. It is essential, however, to include brief references to the research that has made this practical application of it not only possible, but necessary.
The Rhesus Blood Factor
The rhesus, or Rh factor, is a new blood agglutinogen. In-i940, Landsteiner and Weiner injected red cells of the Rhesus monkey into rabbits and guinea pigs. This produced an immune serum, which agglutinated the red cells of 85-per cent. of American Whites, and failed to react with the other 15 per cent. Human bloods agglutinated by this serum were called Rh positive (denoted Rh or R), and those which did not, Rh negative (denoted rh or r).
Arising from the investigation of certain haemolytic transfusion reactions, which showed them due to Rh positive blood being given to Rh negative subjects, or vice versa, it was noted that where such reactions occurred after transfusions in the puerperium, there was often an associated foetal abnormaltiy.
The Genotypes of the Rh Factor
It is advisable, before discussing this associated foetal abnormality, to set out clearly what is meant by the genotypes of the Rh factor. In 8o per cent. of cases the Rh genotypes can be accurately recognized serologically? They represent the fundamental constitution of given individuals. The human cell possesses 24 pairs of chromosomes. At fertilization, with the union of the sperm and ovum, one chromosome of each new pair formed comes from the male side, and the other from the female side. Thus, as far as the Rh factor is concerned, the foetus derives 50 per cent. of its genotype from the father, and 50 per cent. from the mother.
Much, then, depends on whether the parents are. homozygous, that is, their pairs of chromosomnes are identical as regards Rh factor, or whether they are heterozygous, where the pairs of chromosomes are not identical as regards Rh.
A homozygous person is denoted Rh Rh (R.R.) on the positive side, and rh rh (r.r.) on the negative. A heterozygous person is denoted Rh rh (R.r.) , that is, a combination of positive and negative. The Rh negative gene (rh) is recessive, so that a, heterozygous person is always Rh positive.
It can be seen, therefore, that a homozygous Rh positive (Rh Rh) father when mated to an Rh negative (rh rh) wife, can only produce a heterozygous but yet Rh positive child. Once his wife has become sensitized to his Rh positive, his chance of producing an unaffected child is almost nil. On the other hand, a heterozygous father (Rh rh) mated to an Rh negative (rh rh) wife, has a 50 per cent. chance of producing an Rh negative and so unaffected child.
It is, however, not quite such plain sailing as this, because the various allelomorphs of the Rh gene have to be taken into account, as each may produce a different agglutinogen. Also, what can be termed reverse Rh reaction can occur, that is, a homozygous Rh positive (Rh Rh) wife may be sensitized to her husband's Rh negative gene (rh rh, or Rh rh).
The writer's opinion is that the genotype is all important. as regards the prognosis and treatment in cases where the Rh factor is involved, and that such cases can neither be intelligently nor scientifically handled, unless the genotypes of both parents and the child are known.
Examples will be given later of how it is possible to presume, in the absence of genotypes, that a new-born baby is suffering or will suffer from ' haemolytic disease of the new born,' and that its life has been saved by immediate transfusion. The genotypes in such cases will often prove that the occurrence of haemolytic disease of the new born was an impossibility, that the transfusion was quite unnecessary, and the claim to success entirely erroneous. The condition is due to isoimmunization of the mother to an antigen present in the foetal erythroblasts, because of the fact that an Rh negative mother is carrying an Rh positive foetus. An antibody is thus formed in the mother's blood, and it crosses the placental membrane to the foetal circulation, and there destroys foetal red cells, producing the condition of intravascular haemolysis. Javert A significant increase in the cases of demonstrable antibody can be shown by the special techniques such as those of Weiner, Race, etc., for eliciting ' incomplete antibody. ' Sometimes antibody can be detected in the mother's serum 7-IO days after the confinement, where previously all findings were negative. At other times, a child is born which rapidly dies due to kernicterus, and at no time during the pregnancy or the puerperium has it been possible to demonstrate antibody.
Relationship
It has been recommended that where haemolytic disease of the new born can be predicted, that Caesatean section be performed at approximately the 38th week, followed by immediate transfusion of the child. The reason given is that kernicterus probably starts to develop some two weeks prior to full term. It is also claimed that affected babies are prone to asphyxia during their passage through the birth canal.
That kernicterus does commence to develop at, or soon after, birth, and that it progresses rapidly, is not disputed. The writei, however, cannot subscribe to an affected foetus being more prone than any other to asphyxia during birth.
It would seem, that for the present state of knowledge, the pendulum has swung too far. Before such a radical line of treatment could recommend itself to those who practise obstetrics, fuller proof will have to be given (a) that kernicterus does develop before full -term, (b) that normal labour in a multipara prejudices the child's chance of survivalbecause Jabour can always be induced at the 38th week or earlier, (c) that the results obtained by Caesarean section eclipse those by induction.
The writer's experience in predictable cases is that the immediate and distant grave prognosis for the child constitute a very definite contraindication to radical methods, and that conservative lines of treatment can achieve equivalent results. If The baby may look perfectly normal at birth, at full term. Jaundice, however, may appear a few hours after birth and increase very rapidly. This is icterus gravis neonatorum, as opposed to physiological jaundice, which rarely appears earlier than 48 hours after delivery. These babies may also show haemorrhages into mucous membranes under the skin, or from the umbilicus.
Very soon as the jaundice deepens the baby may develop twitchings, irritability of the cerebral type, followed by deep drowsiness, nystagmus rigidity, local or generalized, or even convulsions. Its general condition deteriorates rapidly, and anaemia becomes obvious, despite the jaundice. This signifies kernicterus, which is characterized pathologically by a bright yellow pigmentation of the nuclear structures of the brain. Death usually occurs on the second, third, or fourth day after birth.
In congenital anaemia, the child may appear normal at birth, or look pale and anaemic. Inside two or three days, however, marked pallor and anaemia can be observed, the skin assuming an almost transparent appearance. At birth the liquor amnii and vernix caseosa often have a yellow or orange colour.
As before, the mother's blood, foetal blood and films are sent for examination as soon as the diagnosis is suspected. Here, even though haemolytic disease has already occurred in the family, there is a chance of the baby attaining the same genotype as its mother, and so be unaffected.
Where antibody has been detected during the pregnancy, however, the outlook can be the same as for (a), and can be, even though no antibody has been demonstrable. The only way to find out whether the child has escaped affection, is to ascertain its genotype.
(c) A 4on-anticipated case of haemolytic disease whatever niay be the combination of family genotypes.
Often kernicterus develops, so to speak, with the diagnosis of Rh factor involvement, and the child may die before blood investigation can be completed or treatment given. Of 
Analysis of 100 Cases
When a cross section is taken through ioo cases of the writer's series, a number of interesting and also significant facts are revealed.
Of 33 primiparous Rh negative mothers discovered by routine Rh factor investigation, two were sensitized to their husband's Rh positive. Antibody was demonstrated in their serums, their babies developed haemolytic disease of the new born, were transfused and survived. These two cases, therefore, appear in the number of babies transfused.
Five were married to Rh negative husbands and so the Rh factor was not involved.
Of the remaining 26, 12 were married to homozygous husbands, and I4 to heterozygous husbands. Of these latter, seven achieved Rh negative babies.
Of I9 cases thus left over, all bore live children. Six were entirely normal, but I3, although showing no clinical signs of haemolytic disease of the new born, showed marked, proved and progressive anaemia; three at birth and the others by the fourth to eighth week. All were treated with anahaemin injections and iron by mouth, and have done well.
That such a large proportion showed progressive anaemia gives ground for conjecture, but only a further pregnancy will show whether or not it meant that these mothers had been sensitized by their first conception and whether, in their second, haemolytic disease of the new born should be anticipated.
The other 67 cases were multiparae, investigated either because of their previous history or because the new-born child showed signs of haemolytic disease of the new born. Some few were Rh negative mothers discovered by routine examination.
(a) I2 cases proved not to have been sensitized by previous pregnancy. In five (heterozygous husbands) the first child had been Rh negative. In four other cases the babies showed progressive anaemia by the fourth to eighth week.
(b) I 5 cases showed hydrops foetalis, maceration, death in utero, or premature stillbirth. Antibody was demonstrated in four cases, while two cases showed anti-rh combination without demonstrable antibody.
(c) Eight cases had live-born babies which died of clinical haemolytic disease of the new born before treatment could be given. In two cases antibody was demonstrated.
February, I 947 group.bmj.com on November 6, 2017 -Published by http://pmj.bmj.com/ Downloaded from (d) Two cases with previous histories suggesting haemolytic disease of the new born and with heterozygous husbands, achieved Rh negative babies. To these must be added six cases successfully but unnecessarily transfused, because it was subsequently proved that the baby was Rh negative. Thus eight babies in the series fall into this group.
(e) Four cases proved impossible of successful transfusion. Three had demonstrable antibody and died. One without antibody lived. This case will be featured later.
(f) 26 cases (plus two primiparous cases with antibody) showed the babies successfully transfused.
It is of importance to study in more detail aLhese 28 cases of successful transfusion of the babies.
Four of the cases had repeated transfusion.
Three were anticipated and one not anticipated.
All four cases showed demonstrable antibody. Two survived (one the non-anticipated case) and two died.
Of the other 24 transfused once only, i8 were anticipated and six not so.
Of five that died, antibody was detected in four.
Of i9 that lived, antibody was proved in five cases, while in six cases transfused ;tt birth the transfusion was afterwards proved unnecessary because the baby was Rh negative, the same genotype as the mother. In this series, in 27 multiparous cases with rr mothers, the babies showed clinical manifestations of haemolytic disease of the new born, but no antibody was ever demonstrable. These also must be studied in detail.
Eleven babies died prematurely of hydrops foetalis, maceration, death in utero.
The fathers proved homozygous in ten cases (R1R1) five, (R1R2) five and heterozygous (Rjr) in the i ith.
In six cases death of the baby anticipated treatment. The fathers' genotypes were (R1Rj) four and (R1R2) two.
Eight cases were transfused successfully, and lived, with fathers' genotypes of (R1Rj) two, (R1R2) four and (R2R2 or R2r) two.
One died after transfusion (father RRj) and one lived after failure, to transfuse. In four of the babies that died kernicterus was proved by autopsy.
In 
